An E-Journal for a Vanishing Resource

How can we learn from the exciting times of post-World War II, when American experimental biology was revolutionized and propelled to the forefront of world science, and now, of biotechnology? Part of the answer could be in establishing an electronic journal of the type proposed by former National Institutes of Health director Harold Varmus, one that is not edited or refereed. The unique feature of this journal would be that it is particularly aimed at having retired scientists as authors. Bef

Written byHoward Lenhoff
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

How can we learn from the exciting times of post-World War II, when American experimental biology was revolutionized and propelled to the forefront of world science, and now, of biotechnology? Part of the answer could be in establishing an electronic journal of the type proposed by former National Institutes of Health director Harold Varmus, one that is not edited or refereed. The unique feature of this journal would be that it is particularly aimed at having retired scientists as authors.

Before I suggest some specifics regarding such an electronic journal, consider those post-WW II days. Researchers in the biological sciences now had easy access to such wartime products as radioisotopes and antibiotics. The science faculties of American universities and research institutes were revitalized by the influx of our returning scientists and by scientists who had escaped from Nazi Germany. Our graduate schools flourished with the backlog of students now able ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies